Home » Topics » Regulatory

Regulatory
RSS

Health Canada approves Alprolix for hemophilia B

March 24, 2014

FDA approves Otezla for psoriatic arthritis

March 24, 2014

FDA approves Hemangeol for infantile hemangioma

March 18, 2014

FDA approves intravenous formulation of Noxafil

March 17, 2014

Japanese approval for Poteligeo in PTCL and CTCL

March 17, 2014

Taigexyn approved in Taiwan for CAP

March 13, 2014

Upsher-Smith Laboratories receives FDA approval for Qudexy XR

March 13, 2014

FDA approves Aveed as a testosterone replacement therapy

March 7, 2014

Xolair approved in Europe for chronic spontaneous urticaria

March 7, 2014

Application for approval of an oral disintegrating tablet formulation

Feb. 27, 2014

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...